Diabetic cardiomyopathy: the search for a unifying hypothesis.
about
Cardiovascular Action of Insulin in Health and Disease: Endothelial L-Arginine Transport and Cardiac Voltage-Dependent Potassium ChannelsContractile apparatus dysfunction early in the pathophysiology of diabetic cardiomyopathyAnimal models of diabetic macrovascular complications: key players in the development of new therapeutic approachesEndothelial dysfunction in diabetes mellitus: possible involvement of endoplasmic reticulum stress?The two faces of miR-29Resveratrol treatment reduces cardiac progenitor cell dysfunction and prevents morpho-functional ventricular remodeling in type-1 diabetic ratsCardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterificationClinical Phenotypes in Heart Failure With Preserved Ejection FractionForkhead box transcription factor 1: role in the pathogenesis of diabetic cardiomyopathyDeletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heartTherapeutic inhibition of mitochondrial reactive oxygen species with mito-TEMPO reduces diabetic cardiomyopathyDiabetic cardiomyopathy: signaling defects and therapeutic approachesRegulation of cardiac expression of the diabetic marker microRNA miR-29Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractilityAdverse effects of high glucose and free fatty acid on cardiomyocytes are mediated by connective tissue growth factorDiminished GATA4 protein levels contribute to hyperglycemia-induced cardiomyocyte injuryAdvanced glycation end products promote proliferation of cardiac fibroblasts by upregulation of KCa3.1 channelsDecrease of peroxisome proliferator-activated receptor delta expression in cardiomyopathy of streptozotocin-induced diabetic ratsA thrombospondin-1 antagonist of transforming growth factor-beta activation blocks cardiomyopathy in rats with diabetes and elevated angiotensin IIEnhanced skeletal muscle expression of extracellular superoxide dismutase mitigates streptozotocin-induced diabetic cardiomyopathy by reducing oxidative stress and aberrant cell signaling.Left ventricular hypertrophy and insulin resistance in adults from an urban community in The Gambia: cross-sectional study.Diastolic dysfunction and heart failure with a preserved ejection fraction: Relevance in critical illness and anaesthesiaTRB3 gene silencing alleviates diabetic cardiomyopathy in a type 2 diabetic rat modelConundrum of pathogenesis of diabetic cardiomyopathy: role of vascular endothelial dysfunction, reactive oxygen species, and mitochondria.Role of NAD(P)H oxidase in superoxide generation and endothelial dysfunction in Goto-Kakizaki (GK) rats as a model of nonobese NIDDM.Renal failure increases cardiac histone h3 acetylation, dimethylation, and phosphorylation and the induction of cardiomyopathy-related genes in type 2 diabetes.Diabetes-induced alterations in the extracellular matrix and their impact on myocardial function.Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus.Thioredoxin-1 gene therapy enhances angiogenic signaling and reduces ventricular remodeling in infarcted myocardium of diabetic ratsEffects of Hyperglycemia on Vascular Smooth Muscle Ca2+ SignalingAssociation of glucose metabolism with diastolic function along the diabetic continuumIn vivo administration of urolithin A and B prevents the occurrence of cardiac dysfunction in streptozotocin-induced diabetic rats.Co-activation of nuclear factor-κB and myocardin/serum response factor conveys the hypertrophy signal of high insulin levels in cardiac myoblasts.Deficiency of a lipid droplet protein, perilipin 5, suppresses myocardial lipid accumulation, thereby preventing type 1 diabetes-induced heart malfunctionMolecular determinants of the cardiometabolic phenotype.Changes of myocardial lipidomics profiling in a rat model of diabetic cardiomyopathy using UPLC/Q-TOF/MS analysis.Deficiency of rac1 blocks NADPH oxidase activation, inhibits endoplasmic reticulum stress, and reduces myocardial remodeling in a mouse model of type 1 diabetes.Cardiovascular phenotype in HFpEF patients with or without diabetes: a RELAX trial ancillary study.Thymosin beta 4 prevents oxidative stress by targeting antioxidant and anti-apoptotic genes in cardiac fibroblastsPPARγ-induced cardiolipotoxicity in mice is ameliorated by PPARα deficiency despite increases in fatty acid oxidation.
P2860
Q26751133-5817F993-3C78-4442-A4CE-AE1F229BEB18Q26799594-12499698-D8DA-4128-AFD2-76E8B19F5947Q26822630-A0644AAC-0D2B-4AA2-AC26-BA0C1661F6CFQ26851362-D52C0B44-B290-449D-A74B-46471122721FQ26996481-A0D4DCAE-B8CE-4822-99D1-3F5AED3360F3Q27300198-C35454E5-1331-4CA7-A31C-43ED3089651FQ27887261-FCFBD0D9-88E1-4A7E-A1D6-5B01D1A6D335Q28073079-B7F409A0-8CB1-4288-9D0D-66BEDF024133Q28080067-6A1B6305-8250-4D7E-9555-A6C084C56BC9Q28383474-41C0A5C7-EB6C-40E1-AB32-2605BBC10445Q28391746-088CFE13-8BAF-4C9C-8D95-EA89AFF6DE3DQ28395852-B806650A-E163-470D-BEA6-CBF71618A0B0Q28541217-B690BE97-6DB4-44E0-9C2B-9B4ACCF81D08Q28566976-9A6C7595-AA3C-4D4C-8311-6B8B4CF32FABQ28567041-8C5125BB-8870-4A86-B885-58DF1AB93587Q28569236-80AE5756-D379-4429-A2CF-71F16F6B6CBBQ28570112-609196C6-ECA4-4125-84FD-A2A1A87BDE2EQ28572349-F197048F-B180-4719-9189-66E8C23B8CBCQ28583200-038E58CD-C44F-4916-9CD0-369D79146847Q30301118-091D3DA4-53C7-492D-A9D9-1392489737CEQ30440409-78D7249E-7536-4859-B5F0-95306DF0978EQ30450624-7CC532E6-44F5-4393-A461-FC2B5F33F3F2Q30461459-99C3AF6E-F8F5-4C35-9275-9C742B3F03D0Q33357265-A7F273D6-5556-47E2-8A06-82EF726EE4C8Q33644486-2A2E7DD9-8EFD-46D7-8EB7-4FE714600789Q33703612-91CED691-9801-4ACB-9C97-CE062DF4E39BQ33711031-B3B00A7F-44ED-47E9-8B2D-D8EC953C6C50Q33719419-1095A756-9AD7-4C45-B22A-B8616D088B85Q33782221-6E9BD6B3-1AB2-479A-BB99-9F3FE0D10546Q33872775-929179A6-77B7-486C-9271-FAE353C078F1Q33880289-871C7434-69B5-40A2-BA03-35CFD88E453EQ33883650-26E049E0-4371-4B00-8F2C-EC701B019B9CQ33888579-A33B9C17-777E-4345-B959-B489EBF95AAFQ33899819-B5C73B9A-4BBB-4D58-ABF7-B667281480FFQ33921392-5FEB5CF0-64DB-4FE9-9782-2B3065F55E51Q33921629-AD053673-FE34-45E3-92AF-C4D1DA79A1ABQ34024314-78734923-9AE7-444C-A4E3-78C6904F5212Q34046332-69338DB4-9A6F-48FC-87DD-DF1316E40367Q34064815-EB7D4FC8-AE9A-4FA2-B1BF-6165DACE48E2Q34162103-86CB90DC-8BE2-4624-ACFE-4697B4F75C17
P2860
Diabetic cardiomyopathy: the search for a unifying hypothesis.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@ast
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@en
type
label
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@ast
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@en
prefLabel
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@ast
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@en
P2093
P1433
P1476
Diabetic cardiomyopathy: the search for a unifying hypothesis.
@en
P2093
Indu G Poornima
Pratik Parikh
Richard P Shannon
P304
P356
10.1161/01.RES.0000207406.94146.C2
P577
2006-03-01T00:00:00Z